ABHD17AP5: A Potential Drug Target and Biomarker (G91219)

Target Name: ABHD17AP5

NCBI ID: G91219

ABHD17AP5

ABHD17AP5: A Potential Drug Target and Biomarker

ABHD17AP5 is a gene that encodes a protein with unique structure and function. The protein is a member of the ABH gene family, which is known for their role in the development and maintenance of tissue-specific barriers. The ABH genes have been implicated in a variety of diseases, including drug resistance, wound healing, and skin integrity. The ABHD17AP5 gene has been identified as a pseudogene, which means that it does not encode a functional protein but instead produces a pseud gene that encodes a protein with similar sequence to the original gene.

The protein encoded by the ABHD17AP5 gene is made up of 1,762 amino acids and has a calculated molecular mass of 21.9 kDa. The protein is localized to the endoplasmic reticulum and appears to be involved in the regulation of cell-cell interactions and in the development of tissues.

Potential Drug Target

The unique structure and function of ABHD17AP5 make it an attractive drug target. The protein is involved in the formation of tight junctions, which are a type of cell-cell barrier that helps to maintain tissue integrity. tight junctions are also involved in the regulation of ion and solute transport, as well as the production of specific proteins that are critical for tissue development and maintenance.

ABHD17AP5 has been shown to play a role in the regulation of tight junction formation in various tissues, including the skin and the intestine. Studies have also shown that ABHD17AP5 is involved in the development of cancer, including breast cancer.

Biomarker

ABHD17AP5 has also been identified as a potential biomarker for a variety of diseases, including cancer, wound healing, and drug resistance. The protein is expressed in a variety of tissues and has been shown to be involved in the regulation of cell-cell interactions, which is important for the development and maintenance of tissues and organs.

The expression of ABHD17AP5 has also been shown to be associated with the development of certain diseases, including cancer. Studies have shown that high levels of ABHD17AP5 expression are associated with poor prognosis in patients with breast cancer.

Conclusion

ABHD17AP5 is a gene that has unique structure and function, and its potential as a drug target and biomarker make it an attractive target for further investigation. The protein encoded by the ABHD17AP5 gene is involved in the regulation of cell-cell interactions and in the development of tissues, and its unique structure and function make it an attractive target for drug development. Further studies are needed to fully understand the role of ABHD17AP5 in the regulation of cell-cell interactions and in the development of diseases.

Protein Name: ABHD17A Pseudogene 5

The "ABHD17AP5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ABHD17AP5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets